165 related articles for article (PubMed ID: 23733714)
1. Acute psychosis associated with recreational use of benzofuran 6-(2-aminopropyl)benzofuran (6-APB) and cannabis.
Chan WL; Wood DM; Hudson S; Dargan PI
J Med Toxicol; 2013 Sep; 9(3):278-81. PubMed ID: 23733714
[TBL] [Abstract][Full Text] [Related]
2. Acute Toxicity Associated With the Recreational Use of the Novel Psychoactive Benzofuran N-methyl-5-(2 aminopropyl)benzofuran.
Hofer KE; Faber K; Müller DM; Hauffe T; Wenger U; Kupferschmidt H; Rauber-Lüthy C
Ann Emerg Med; 2017 Jan; 69(1):79-82. PubMed ID: 27156124
[TBL] [Abstract][Full Text] [Related]
3. Severe toxicity following synthetic cannabinoid ingestion.
Lapoint J; James LP; Moran CL; Nelson LS; Hoffman RS; Moran JH
Clin Toxicol (Phila); 2011 Oct; 49(8):760-4. PubMed ID: 21970775
[TBL] [Abstract][Full Text] [Related]
4. Emerging club drugs: 5-(2-aminopropyl)benzofuran (5-APB) is more toxic than its isomer 6-(2-aminopropyl)benzofuran (6-APB) in hepatocyte cellular models.
Roque Bravo R; Carmo H; Silva JP; Valente MJ; Carvalho F; Bastos ML; Dias da Silva D
Arch Toxicol; 2020 Feb; 94(2):609-629. PubMed ID: 31838565
[TBL] [Abstract][Full Text] [Related]
5. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
[TBL] [Abstract][Full Text] [Related]
6. Delayed onset of seizures and toxicity associated with recreational use of Bromo-dragonFLY.
Wood DM; Looker JJ; Shaikh L; Button J; Puchnarewicz M; Davies S; Lidder S; Ramsey J; Holt DW; Dargan PI
J Med Toxicol; 2009 Dec; 5(4):226-9. PubMed ID: 19876858
[TBL] [Abstract][Full Text] [Related]
7. Metabolic patterns of JWH-210, RCS-4, and THC in pig urine elucidated using LC-HR-MS/MS: Do they reflect patterns in humans?
Schaefer N; Helfer AG; Kettner M; Laschke MW; Schlote J; Ewald AH; Meyer MR; Menger MD; Maurer HH; Schmidt PH
Drug Test Anal; 2017 Apr; 9(4):613-625. PubMed ID: 27328899
[TBL] [Abstract][Full Text] [Related]
8. Metabolic fate, mass spectral fragmentation, detectability, and differentiation in urine of the benzofuran designer drugs 6-APB and 6-MAPB in comparison to their 5-isomers using GC-MS and LC-(HR)-MS(n) techniques.
Welter J; Brandt SD; Kavanagh P; Meyer MR; Maurer HH
Anal Bioanal Chem; 2015 May; 407(12):3457-70. PubMed ID: 25711990
[TBL] [Abstract][Full Text] [Related]
9. Presentations due to acute toxicity of psychoactive substances in an urban emergency department in Switzerland: a case series.
Liakoni E; Dolder PC; Rentsch KM; Liechti ME
BMC Pharmacol Toxicol; 2016 May; 17(1):25. PubMed ID: 27228985
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic effects of psychotropic benzofuran derivatives, N-methyl-5-(2-aminopropyl)benzofuran and its N-demethylated derivative, on isolated rat hepatocytes.
Nakagawa Y; Suzuki T; Tada Y; Inomata A
J Appl Toxicol; 2017 Mar; 37(3):243-252. PubMed ID: 27291301
[TBL] [Abstract][Full Text] [Related]
11. First reported case in the UK of acute prolonged neuropsychiatric toxicity associated with analytically confirmed recreational use of phenazepam.
Dargan PI; Davies S; Puchnarewicz M; Johnston A; Wood DM
Eur J Clin Pharmacol; 2013 Mar; 69(3):361-3. PubMed ID: 22843017
[TBL] [Abstract][Full Text] [Related]
12. Acute toxicity associated with analytically confirmed recreational use of methiopropamine (1-(thiophen-2-yl)-2-methylaminopropane).
Lee HM; Wood DM; Hudson S; Archer JR; Dargan PI
J Med Toxicol; 2014 Sep; 10(3):299-302. PubMed ID: 24706157
[TBL] [Abstract][Full Text] [Related]
13. Toxic cannabis psychosis is a valid entity.
Solomons K; Neppe VM; Kuyl JM
S Afr Med J; 1990 Oct; 78(8):476-81. PubMed ID: 2218786
[TBL] [Abstract][Full Text] [Related]
14. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial.
Tomko RL; Baker NL; McClure EA; Sonne SC; McRae-Clark AL; Sherman BJ; Gray KM
Drug Alcohol Depend; 2018 Jan; 182():1-7. PubMed ID: 29112827
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.
Tait RJ; Caldicott D; Mountain D; Hill SL; Lenton S
Clin Toxicol (Phila); 2016; 54(1):1-13. PubMed ID: 26567470
[TBL] [Abstract][Full Text] [Related]
16. Synthetic cannabinoids: A review of the clinical implications of a new drug of choice.
Freund SA; Banning AS
JAAPA; 2017 Nov; 30(11):1-4. PubMed ID: 29064946
[TBL] [Abstract][Full Text] [Related]
17. Psychosis associated with acute recreational drug toxicity: a European case series.
Vallersnes OM; Dines AM; Wood DM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; ; Dargan PI
BMC Psychiatry; 2016 Aug; 16():293. PubMed ID: 27538886
[TBL] [Abstract][Full Text] [Related]
18. Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine.
Wood DM; Davies S; Puchnarewicz M; Johnston A; Dargan PI
Eur J Clin Pharmacol; 2012 May; 68(5):853-6. PubMed ID: 22205276
[TBL] [Abstract][Full Text] [Related]
19. Intoxication by a synthetic cannabinoid (JWH-018) causes cognitive and psychomotor impairment in recreational cannabis users.
Theunissen EL; Reckweg JT; Hutten NRPW; Kuypers KPC; Toennes SW; Neukamm MA; Halter S; Ramaekers JG
Pharmacol Biochem Behav; 2021 Mar; 202():173118. PubMed ID: 33497715
[TBL] [Abstract][Full Text] [Related]
20. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens.
Haschimi B; Mogler L; Halter S; Giorgetti A; Schwarze B; Westphal F; Fischmann S; Auwärter V
Drug Test Anal; 2019 Sep; 11(9):1377-1386. PubMed ID: 31228224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
